Profilo
Mr. Richard A. Fair is a Chief Executive Officer & Director at Enliven Therapeutics, Inc. /US/, a President, Chief Executive Officer & Director at Enliven Therapeutics, Inc. and a President & Director at Bellicum Pharmaceuticals, Inc. He is on the Board of Directors at Enliven Therapeutics, Inc. /US/, Enliven Therapeutics, Inc. and Bellicum Pharmaceuticals, Inc. Mr. Fair was previously employed as an Independent Director by Clovis Oncology, Inc., a SVP & Head-Therapeutic Oncology Global Product by Genentech, Inc., and a Franchise Head-Hematology by Roche Pharma (Schweiz) AG.
He received his undergraduate degree from the University of Michigan and an MBA from Columbia Business School.
Posizioni attive di Richard Fair
| Società | Posizione | Inizio |
|---|---|---|
| BELLICUM PHARMACEUTICALS, INC. | Presidente | 31/01/2017 |
| ENLIVEN THERAPEUTICS, INC. | Amministratore Delegato | 11/12/2025 |
Enliven Therapeutics, Inc. /US/
Enliven Therapeutics, Inc. /US/ BiotechnologyHealth Technology Engages in discovery and development of small molecule treatments for cancer | Amministratore Delegato | 11/12/2025 |
Precedenti posizioni note di Richard Fair
| Società | Posizione | Fine |
|---|---|---|
| CLOVIS ONCOLOGY, INC. | Direttore/Membro del Consiglio | 10/07/2023 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | 01/01/2017 |
Roche Pharma (Schweiz) AG
Roche Pharma (Schweiz) AG Medical DistributorsDistribution Services Wholesales pharmaceutical products | Corporate Officer/Principal | - |
Formazione di Richard Fair
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 8 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Bellicum Pharmaceuticals, Inc.
Bellicum Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel cellular immunotherapies for various forms of cancer | Health Technology |
University of Michigan
University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Clovis Oncology, Inc.
Clovis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as an biopharmaceutical company that acquires, develops and commercializes innovative anti cancer agents | Health Technology |
Roche Pharma (Schweiz) AG
Roche Pharma (Schweiz) AG Medical DistributorsDistribution Services Wholesales pharmaceutical products | Distribution Services |
Columbia Business School
Columbia Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Enliven Therapeutics, Inc. /US/
Enliven Therapeutics, Inc. /US/ BiotechnologyHealth Technology Engages in discovery and development of small molecule treatments for cancer | Health Technology |
Enliven Therapeutics, Inc.
Enliven Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage precision oncology company that develops molecule therapies | Health Technology |
















